MUTYH and polyposis: In particular, the MUTYH p.(Gly368Asp) and p.(Tyr151Cys) variants are well-established pathogenic variants for MUTYH-related polyposis and are estimated to account for 50–82% of MUTYH-associated polyposis in European patients (24).